Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001104659-21-043650
Filing Date
2021-03-30
Accepted
2021-03-30 07:48:48
Documents
1
Effectiveness Date
2021-03-30
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12692
  Complete submission text file 0001104659-21-043650.txt   13996
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-393952 | Film No.: 21783652
SIC: 2834 Pharmaceutical Preparations